Philippe C. Bishop - Jan 9, 2023 Form 4 Insider Report for Atreca, Inc. (BCEL)

Role
Chief Medical Officer
Signature
/s/ Courtney Phillips, attorney-in-fact
Stock symbol
BCEL
Transactions as of
Jan 9, 2023
Transactions value $
$0
Form type
4
Date filed
1/11/2023, 05:44 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCEL Employee stock option (right to buy) Award $0 +350K $0.00 350K Jan 9, 2023 Class A Common Stock 350K $1.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares of Class A common stock underlying the Option shall vest on January 9, 2024 and the remainder of the shares of Class A common stock underlying the Option shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.